NEW YORK (GenomeWeb News) – Becton Dickinson today reported a 6 percent increase year over year in its revenues for fiscal first quarter 2014, while its profits were more than halved.

For the three months ended Dec. 31, 2013, BD posted revenues of $2.02 billon, compared to $1.90 billion a year ago, and beating the average analyst estimate of $1.98 billion. In a statement, the firm said that revenue growth came partly from favorable timing of orders in the BD Medical and BD Diagnostics segments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.